Legal & General Group Plc Sells 3,918 Shares of Definitive Healthcare Corp. (NASDAQ:DH)

Legal & General Group Plc trimmed its holdings in shares of Definitive Healthcare Corp. (NASDAQ:DH) by 9.5% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 37,427 shares of the company’s stock after selling 3,918 shares during the period. Legal & General Group Plc’s holdings in Definitive Healthcare were worth $154,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also added to or reduced their stakes in DH. Geode Capital Management LLC raised its holdings in Definitive Healthcare by 3.2% during the 4th quarter. Geode Capital Management LLC now owns 1,272,660 shares of the company’s stock valued at $5,231,000 after acquiring an additional 39,938 shares during the period. New York State Common Retirement Fund boosted its stake in shares of Definitive Healthcare by 3.2% during the fourth quarter. New York State Common Retirement Fund now owns 771,792 shares of the company’s stock valued at $3,172,000 after purchasing an additional 23,815 shares during the period. JPMorgan Chase & Co. grew its position in shares of Definitive Healthcare by 49.2% in the 4th quarter. JPMorgan Chase & Co. now owns 331,264 shares of the company’s stock worth $1,361,000 after buying an additional 109,174 shares during the last quarter. Bank of New York Mellon Corp raised its stake in Definitive Healthcare by 35.9% in the fourth quarter. Bank of New York Mellon Corp now owns 229,143 shares of the company’s stock worth $942,000 after buying an additional 60,559 shares in the last quarter. Finally, PNC Financial Services Group Inc. lifted its position in Definitive Healthcare by 928.3% during the 4th quarter. PNC Financial Services Group Inc. now owns 156,997 shares of the company’s stock valued at $645,000 after acquiring an additional 141,729 shares during the period. Institutional investors own 98.67% of the company’s stock.

Definitive Healthcare Stock Up 1.1 %

Shares of NASDAQ DH opened at $2.75 on Friday. Definitive Healthcare Corp. has a 1 year low of $2.15 and a 1 year high of $7.47. The company has a market capitalization of $296.90 million, a price-to-earnings ratio of -0.89, a price-to-earnings-growth ratio of 4.06 and a beta of 1.48. The company has a debt-to-equity ratio of 0.33, a current ratio of 2.49 and a quick ratio of 2.49. The business has a 50-day moving average of $2.83 and a two-hundred day moving average of $3.94.

Definitive Healthcare (NASDAQ:DH) last posted its earnings results on Thursday, February 27th. The company reported $0.03 EPS for the quarter, missing analysts’ consensus estimates of $0.07 by ($0.04). The firm had revenue of $62.29 million for the quarter, compared to analyst estimates of $60.60 million. Definitive Healthcare had a positive return on equity of 1.76% and a negative net margin of 142.38%. On average, analysts forecast that Definitive Healthcare Corp. will post 0.16 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

DH has been the subject of several research analyst reports. Barclays cut their price objective on Definitive Healthcare from $4.00 to $3.00 and set an “underweight” rating for the company in a report on Monday, March 3rd. The Goldman Sachs Group decreased their target price on shares of Definitive Healthcare from $4.50 to $3.00 and set a “neutral” rating on the stock in a research report on Tuesday, March 4th. Finally, Needham & Company LLC reissued a “hold” rating on shares of Definitive Healthcare in a research note on Thursday, January 16th. Two analysts have rated the stock with a sell rating, seven have assigned a hold rating and three have issued a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $5.35.

Definitive Healthcare Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.